BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26427586)

  • 1. Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: Relationship with diastolic dysfunction.
    Filì D; Falletta C; Luca A; Hernandez Baravoglia C; Clemenza F; Miraglia R; Scardulla C; Tuzzolino F; Vizzini G; Gridelli B; Bosch J
    Dig Liver Dis; 2015 Dec; 47(12):1052-8. PubMed ID: 26427586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamic response in cirrhotic patients with transjugular intrahepatic portosystemic shunt].
    Wang JF; Ma JQ; Luo JJ; Chen HY; Mi SL; Chen SY; Su YG; Ge JB
    Zhonghua Nei Ke Za Zhi; 2020 Sep; 59(9):700-705. PubMed ID: 32838501
    [No Abstract]   [Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt in refractory ascites: clinical impact of left ventricular diastolic dysfunction.
    Debernardi Venon W; Lo Pumo S; Imperatrice B; Giorgi M; Righi D; Fonio P; Saracco GM; Marzano A
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e464-e470. PubMed ID: 33867443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.
    Rabie RN; Cazzaniga M; Salerno F; Wong F
    Am J Gastroenterol; 2009 Oct; 104(10):2458-66. PubMed ID: 19532126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis.
    Busk TM; Bendtsen F; Poulsen JH; Clemmesen JO; Larsen FS; Goetze JP; Iversen JS; Jensen MT; Møgelvang R; Pedersen EB; Bech JN; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G275-G286. PubMed ID: 29074483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.
    Huonker M; Schumacher YO; Ochs A; Sorichter S; Keul J; Rössle M
    Gut; 1999 May; 44(5):743-8. PubMed ID: 10205217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
    Garcia-Tsao G
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
    Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
    Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
    Tan HK; James PD; Sniderman KW; Wong F
    J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results.
    Kovács A; Schepke M; Heller J; Schild HH; Flacke S
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):290-6. PubMed ID: 19730936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study.
    Maleux G; Perez-Gutierrez NA; Evrard S; Mroue A; Le Moine O; Laleman W; Nevens F
    Acta Gastroenterol Belg; 2010; 73(3):336-41. PubMed ID: 21086935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function.
    Van der Linden P; Le Moine O; Ghysels M; Ortinez M; Devière J
    Hepatology; 1996 May; 23(5):982-7. PubMed ID: 8621179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular Intrahepatic Portosystemic Shunt: The Toulouse Algorithm.
    Billey C; Billet S; Robic MA; Cognet T; Guillaume M; Vinel JP; Péron JM; Lairez O; Bureau C
    Hepatology; 2019 Dec; 70(6):1928-1941. PubMed ID: 31512743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.
    Colombato LA; Spahr L; Martinet JP; Dufresne MP; Lafortune M; Fenyves D; Pomier-Layrargues G
    Gut; 1996 Oct; 39(4):600-4. PubMed ID: 8944572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS).
    Merli M; Valeriano V; Funaro S; Attili AF; Masini A; Efrati C; De CS; Riggio O
    Am J Gastroenterol; 2002 Jan; 97(1):142-8. PubMed ID: 11808939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
    Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
    Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.
    Gaba RC; Parvinian A; Casadaban LC; Couture PM; Zivin SP; Lakhoo J; Minocha J; Ray CE; Knuttinen MG; Bui JT
    Clin Radiol; 2015 May; 70(5):e51-7. PubMed ID: 25758602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.